Mirae Asset Global Etfs Holdings Ltd. Nkarta, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Nkarta, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 29,087 shares of NKTX stock, worth $68,063. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,087
Previous 14,643
98.64%
Holding current value
$68,063
Previous $86,000
52.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NKTX
# of Institutions
127Shares Held
66.6MCall Options Held
173KPut Options Held
20K-
Ra Capital Management, L.P. Boston, MA10.8MShares$25.3 Million0.68% of portfolio
-
Commodore Capital LP New York, NY4.66MShares$10.9 Million1.79% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$9.5 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA4.03MShares$9.43 Million0.97% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$8.82 Million9.87% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $114M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...